Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or ...

据媒体最新透露的消息，其他随行的美国华尔街投资机构高管还包括来自黑石集团的共同创始人兼首席 执行官苏世民(SteveSchwarzman)、来自富兰克林邓普顿的珍妮·约翰逊，以及来自谷歌母公司Alphabet Inc.的首席财务官露丝·珀拉特(RuthPorat)。 智通财经APP获悉，据媒体报道，全球最大规模资管巨头贝莱德公司(BlackRock )的首席执行官拉里·芬 克、华尔街金融巨头花旗集团(Citigroup Inc.)首席执行官简·弗雷泽以及多位来自硅谷的美国科技巨头高 管们，将在下周随美国总统唐纳德·特朗普一起访问中东经济大国——沙特阿拉伯。 据媒体报道，这些来自华尔街和硅谷的高管们计划将于5月13日在利雅得的"沙美投资论坛"上发表重要 演讲。在论坛举办当日，特朗普将抵达沙特并预计会晤沙特王储穆罕默德·本·萨勒曼。 重返白宫的美国总统特朗普也将前往卡塔尔和阿联酋，这是其重新掌权以来的首次出访。他希望这些富 含油气资源的海湾国家加大对美国的投资并购买更多的美国制造与生产的各项重要产品。 据了解，来自美国老牌科技巨头IBM的首席执行官阿文德·克里希纳以及来自美国智能手机与汽车芯片 领军者高通公司(Q ...

Core Insights - President Donald Trump is set to visit Saudi Arabia, Qatar, and the UAE, marking his first pre-arranged overseas trip since taking office [1] - The visit aims to encourage Gulf nations to increase investments in the U.S. and purchase more American goods, with a target of $1 trillion in investments from Saudi Arabia [1] - High-profile executives from major companies, including BlackRock, Citigroup, and various tech firms, will accompany Trump and participate in the Saudi-U.S. Investment Forum [1] Group 1 - The visit includes key executives such as Larry Fink from BlackRock and Jane Fraser from Citigroup, indicating strong corporate interest in the Gulf region [1] - The Saudi-U.S. Investment Forum will cover topics such as energy, artificial intelligence, advanced manufacturing, and finance, highlighting the focus on innovation and investment opportunities [1] - Notable attendees will include Saudi Aramco's CEO Amin Nasser and Saudi ministers of energy, investment, and finance, emphasizing the importance of government and corporate collaboration [1]

Group 1 - Elanco Animal Health announced the sale of future tiered royalties and commercial milestones related to Xdemvy for $295 million in cash, aimed at accelerating debt reduction [1] - The proceeds from the sale will help Elanco achieve a net leverage ratio of 3.9x to 4.3x adjusted EBITDA by the end of 2025 [1] - Elanco plans to repay portions of its outstanding term loans, which is expected to reduce interest expenses by approximately $10 million [2] Group 2 - Xdemvy, the first lotilaner-based product approved for human use, addresses Demodex blepharitis and is licensed to Tarsus Pharmaceuticals for exploration of human health applications [3] - The agreement covers tiered royalties on Xdemvy's U.S. net sales from April 2025 through August 2033 [3] - Elanco retains rights to all royalty payments on net sales outside the U.S. and any future human applications of lotilaner beyond ophthalmic solutions [4] Group 3 - Elanco is scheduled to release its Q1 2025 financial results, with analysts expecting adjusted earnings per share of 31 cents and sales of $1.21 billion [4] - The current stock price of Elanco is $9.75, which is below the 200-day moving average of $12.34, indicating potential bearish sentiment [6] - Recent trading saw Elanco's stock decrease by 1.03% to $9.65 [7]

Core Insights - Elanco Animal Health announced the sale of future tiered royalties and commercial milestones related to XDEMVY for $295 million in cash, aimed at accelerating debt reduction and achieving a net leverage ratio of 3.9x to 4.3x adjusted EBITDA by the end of 2025 [1][3] - The agreement includes royalties from U.S. net sales of XDEMVY from April 2025 through August 2033, while Elanco retains rights to royalties from sales outside the U.S. and future human applications of lotilaner beyond ophthalmic solutions [4] Company Overview - Elanco is a global leader in animal health, dedicated to innovating products and services for disease prevention and treatment in farm animals and pets, with a 70-year heritage in the industry [7] - The company is focused on high-impact innovation and aims to enhance core business sales growth in 2025, leveraging the cash from the royalty sale to support its deleveraging goals [3] Product Development - Lotilaner was exclusively licensed to Tarsus Pharmaceuticals in 2019 for human health applications, and in 2023, XDEMVY became the first lotilaner-based product approved for human use, specifically for treating Demodex blepharitis [2][4] - The collaboration between Elanco and Tarsus has led to the rapid adoption and commercial success of XDEMVY, addressing a significant health need for patients suffering from a common eyelid disease [3]

Economic Overview - Blackstone reported a total return of the S&P 500 index at (4.3)% for Q1 2025, with significant declines in consumer discretionary and information technology sectors of 13.8% and 12.7% respectively [269]. - The U.S. economy contracted by 0.3% in Q1 2025, down from a growth of 2.4% in Q4 2024, indicating a slowdown in economic activity [270]. - U.S. inflation decelerated to 2.4% in March 2025, down from a peak of 9.1% in June 2022 [270]. - The unemployment rate remained steady at 4.2% in March 2025, compared to 4.1% in December 2024 [271]. - Global markets experienced significant volatility in Q1 2025, influenced by U.S. trade policies and a weakening U.S. Dollar, with the 10-year U.S. Treasury yield decreasing by 36 basis points to 4.21% [268]. Financial Performance - Revenues for the three months ended March 31, 2025, were $3.3 billion, a decrease of $398.4 million (11%) compared to $3.7 billion for the same period in 2024 [308]. - Total Investment Income decreased by $469.2 million (29%) to $1.2 billion, primarily due to a $485.7 million decrease in Unrealized Investment Income [308]. - Total Expenses increased by $104.0 million (6%) to $1.9 billion, driven by a $123.5 million increase in Total Compensation and Benefits [309]. - Net Income for the three months ended March 31, 2025, was $1.2 billion, a decrease of $387.2 million (24%) compared to $1.6 billion in 2024 [308]. - The effective tax rate for the three months ended March 31, 2025, was 16.8%, compared to 15.1% for the same period in 2024 [312]. Assets Under Management - Total Assets Under Management includes both invested and available capital in Blackstone-managed or advised vehicles, with the measurement varying based on the structure and investment strategy of each vehicle [293]. - Total Assets Under Management increased to $1,167,461,910, reflecting a growth of 4% compared to the previous year [325]. - Fee-Earning Assets Under Management rose to $860,069,950, marking an increase of 4% year-over-year [325]. - The impact of foreign exchange rate fluctuations on Total Assets Under Management was $4.5 billion for the three months ended March 31, 2025 [327]. - Total Assets Under Management increased by $40.3 billion to $1,167.5 billion as of March 31, 2025, compared to $1,127.2 billion at December 31, 2024 [328]. Segment Performance - The Corporate Private Equity business focuses on control-oriented investments in high-quality companies, aiming for strong unlevered returns regardless of market cycles [254]. - The Blackstone Real Estate Partners (BREP) platform targets a broad range of opportunistic real estate investments, focusing on high-quality assets with outsized growth potential driven by global economic trends [248]. - The Blackstone Infrastructure Partners (BIP) strategy targets a diversified mix of core+, core, and public-private partnership investments across all infrastructure sectors [257]. - The Multi-Asset Investing segment is the world's largest discretionary allocator to hedge funds, seeking to deliver compelling risk-adjusted returns through public market strategies [264]. - Segment Distributable Earnings for Multi-Asset Investing were $55.7 million for the three months ended March 31, 2025, a 9% increase from $50.9 million in 2024 [410]. Compensation and Earnings - Distributable Earnings for the three months ended March 31, 2025, was impacted by an increase of $21.3 million in Realized Performance Compensation, which reduced Net Realizations and negatively affected Income Before Provision (Benefit) for Taxes and Distributable Earnings [284]. - Fee Related Earnings for Q1 2025 were $484.8 million, a decrease of $101.2 million compared to $586.1 million in Q1 2024, mainly due to a drop in Fee Related Performance Revenues [363]. - Management Fees, Net were $700.8 million for the three months ended March 31, 2025, a decrease of $19.6 million or 2.7% compared to $720.4 million for the same period in 2024 [365]. - Realized Performance Revenues decreased to $350.1 million for the three months ended March 31, 2025, down $99.8 million or 22% compared to $449.9 million for the same period in 2024 [382]. - Realized Performance Compensation was $171.1 million for the three months ended March 31, 2025, a decrease of $49.3 million or 22% compared to $220.5 million for the same period in 2024 [383]. Investment Strategies and Returns - The Credit & Insurance segment has benefited from high interest rates, although a decline in rates could impact future performance [393]. - Private Credit composite gross returns were 3% for the three months ended March 31, 2025, compared to 4% in 2024, while Liquid Credit composite gross returns decreased to 1% from 2% [404]. - The Absolute Return Composite achieved a gross return of 3% for the three months ended March 31, 2025, compared to 5% in 2024, with a one-year average annual return of 11% [421]. - The BXMT Total Net Return reflects an annualized market return of a shareholder invested since inception, with a significant focus on real estate debt strategies [358]. - The BIP Total Assets Under Management reached $59.0 billion, indicating strong institutional interest in infrastructure-focused funds [358].

Group 1 - The article highlights Blackstone Mortgage Trust (NYSE: BXMT) as a noteworthy real estate finance company that originates senior loans [1] - Binary Tree Analytics (BTA) aims to provide transparency and analytics in capital markets, focusing on CEFs, ETFs, and Special Situations, with a goal of delivering high annualized returns and low volatility [1] Group 2 - The author has a beneficial long position in BXMT shares through various financial instruments [2]

Core Viewpoint - Blackstone is considering the sale of Sphera, a tech company specializing in sustainability and risk management software, which has led to a decline in its stock price [1][2]. Group 1: Company Overview - Blackstone is a powerful investment management company that experienced a stock decline of over 1% amid news of the potential sale of Sphera [1]. - Sphera generates annual revenue exceeding $300 million and serves over 8,400 clients globally, including major companies like Mercedes-Benz and Siemens [3]. Group 2: Sale Details - Blackstone is reportedly in the early stages of selling Sphera, with potential proceeds from the sale estimated at nearly $3 billion [2][3]. - Investment bankers have been hired to manage the sale process, indicating a strategic move by Blackstone to be more proactive in portfolio sell-offs this year compared to the previous year [2][4]. Group 3: Market Reaction - The news of the potential sale has caused investor concern, reflected in Blackstone's stock performance, which contrasts with a slight gain in the S&P 500 [1][2]. - There is speculation among investors regarding the implications of divesting a successful asset like Sphera from Blackstone's portfolio [4].

Core Viewpoint - Sun Communities, Inc. has completed the initial closing of the sale of its interests in Safe Harbor Marinas to Blackstone Infrastructure, marking a strategic shift towards focusing on its core manufactured housing (MH) and recreational vehicle (RV) portfolio [1][2]. Financial Impact - The pre-tax cash proceeds from the transaction are approximately $5.25 billion, with certain properties valued at around $250 million excluded from the initial closing, pending third-party consents [3]. - The company plans to repay approximately $3.3 billion of debt using the net proceeds, which includes $1.6 billion from its senior credit facility and $740 million of secured mortgage debt [6]. - The expected annualized interest expense savings from the initial debt paydowns is approximately $160 million, reducing the weighted average interest rate on outstanding indebtedness to about 3.5% [7]. Strategic Focus - The company aims to reposition itself as a pure-play MH and RV focused entity, enhancing its leverage profile and financial flexibility to support disciplined growth [2][4]. - Approximately $1.0 billion has been allocated into 1031 exchange escrow accounts for potential future MH and RV acquisitions on a tax-efficient basis [8]. Capital Return Strategy - A one-time special cash distribution of $4.00 per share, totaling around $520 million, has been authorized by the Board of Directors, payable on May 22, 2025 [9]. - The company intends to increase its quarterly distribution by approximately 10.6% to $1.04 per common share, starting with the second quarter distribution anticipated in July 2025 [9][10]. - A stock repurchase program of up to $1.0 billion has been authorized, allowing management discretion in executing repurchases [11]. Upcoming Events - The company is scheduled to report its first quarter earnings for 2025 on May 5, 2025, and will provide updated guidance reflecting the financial impact of the initial closing [13].

Blackstone Mortgage Trust, Inc. Q1 2025 Company Presentation Blackstone Mortgage Trust, Inc. BLACKSTONE MORTGAGE TRUST OVERVIEW ▪ Blackstone Mortgage Trust (BXMT) is a publicly traded commercial mortgage REIT focused on real estate credit investments in North America, Europe, and Australia | | ▪ BXMT is managed by Blackstone, the largest owner of commercial real estate globally with $602B of TEV,(a) providing full access to the data and | | --- | --- | | Preeminent Sponsorship | resources of the Blackstone ...